Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacin

Lomefloxacin was found to be comparable to ciprofloxacin in its ability to inhibit the in vitro growth of Mycoplasma pneumoniae (MIC range 2–8 mcg/ml), but it was significantly less active than erythromycin. Although 30 different strains from widely differing geographic areas and isolation time peri...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diagnostic microbiology and infectious disease 1989-09, Vol.12 (5), p.433-435
Hauptverfasser:	Cassell, G.H., Waites, K.B., Pate, M.S., Canupp, K.C., Duffy, L.B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Infective Agents - pharmacology Antibiotics (antibacterial agents, antifungal agents) Antibiotics, microbial producers, chemotherapic agents, antiseptics, disinfecting agents Applied microbiology Biological and medical sciences Ciprofloxacin - pharmacology Erythromycin - pharmacology Fluoroquinolones Fundamental and applied biological sciences. Psychology Humans Microbiology Mycoplasma pneumoniae - drug effects Quinolones
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!